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FREE BOUNDARY PROBLEMS IN CONTROLLED RELEASE
PHARMACEUTICALS II. SWELLING-CONTROLLED RELEASE*
DONALD S. COHENf AND THOMAS ERNEUXt
Abstract. A problem in controlled release pharmaceutical systems is formulated and studied. The device
modeled is a polymer matrix containing an initially immobilized drug. The release of the drug is achieved
by countercurrent diffusion through a penetrant solvent with the release rate being determined by the rate
of diffusion of the solvent in the polymer. The mathematical theory yields a free boundary problem which
is studied in various asymptotic regimes.
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1. Introduction. When a glassy polymer is placed in contact with a penetrant
solvent, a glassy-rubbery interface appears and moves through the polymer. For some
polymer-penetrant systems, the interface velocity is constant for small times T (zero
order or Case II diffusion) but may vary as T-1/2 at larger times (Fickian diffusion).
The diffusive transport of the solvents for the various systems are modeled mathemati-
cally as moving boundary problems which are difficult to solve. In a previous paper
[10] we analyzed two different types of controlled release pharmaceutical systems in
which a drug is released in proportion to the rate of transport of a penetrant solvent
into a glassy polymer. In both cases we found that the penetrant front moves initially
at a constant rate, and our asymptotic analysis allowed us to determine the optimal
conditions on the parameters for zero order release.
In the present paper we formulate and analyze the following more complex
controlled release pharmaceutical system: A drug or bioactive agent is initially immobi-
lized in a glassy polymer. The release of the drug then results from the diffusion of
the dissolved drug under the countercurrent diffusion of a solvent (e.g., water or a
biological fluid) into the polymer. However, it is the penetrating dissolution medium
that is the controlling factor in the swellable polymeric system. To analyze mathemati-
cally the swelling-controlled release of the drug, we propose combining the Higuchi
model [3a], [3b] for the transport of the drug and the Astarita and Sarti model [4] for
the transport of the solvent. For the part of the model involving the latter case, our
previous study [10] of specific polymer-penetrant systems will be relevant. Our com-
bined model is similar to the problem studied by Peppas et al. [5] except for the
conditions at the moving fronts.
In 2, we reexamine the Higuchi model for the release of drugs in matrix devices.
In these devices, the surrounding fluid plays a minor role. It is the dissolution of the
drug which is the rate-limiting step in the release process. We show that the steady
state approximation proposed by Higuchi represents the leading term of an asymptotic
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expansion of the solution. This expansion will then be used in 3, when we describe
the diffusion of the drug and the penetrant in swellable polymers.
2. Matrix-controlled release Ill]. Matrix devices may contain the drug at an initial
loading Ao which is significantly higher than the drug solubility in the matrix. In
contact with a dissolution medium, the drug diffuses through the polymer and the
dissolution of the solute may be the rate-limiting step of the release process. A popular
model describing this case was proposed by Higuchi in 1961 [3a]. The model has been
supported by many kinetic studies and improved in several ways [7], [8]. A schematic
diagram of drug release from a slab is shown in Fig. 1. At time 0, the matrix device
(-Xo <X < Xo) contains dispersed drug and is in contact with the dissolution medium
(X <-Xo and X > Xo). At time T, the drug dissolves from the surface layer of the
device. An interface between dissolved and dispersed drug then moves into the interior.
As is defined as the solute solubility of the drug in the polymer. The polymer does not
swell during the release process and the release medium is a perfect sink. The diffusion
of the solute through the dissolved matrix phase is then described by the following
equations:
(2.1) AT DaAxx, S(T) < X < Xo,
(2.2) A=0 atX=Xo,
(2.3) A=As
at X S(T),(2.4)
-DdAx (As Ao)S’
A
Ao
0 Xo
Time O
-Xo -S(T)
Ao
S(T) Xo -X
Time T
FIG. l. Matrix-controlled release. The concentration of the drug A is represented as a function of X. The
cross-hatched region corresponds to the region ofthe matrix where the drug is dispersed and has not been dissolved.
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(2.5) S(0) Xo, S(T) > 0.
The boundary condition (2.2) describes the perfect sink of the drug, (2.4) is a mass
balance equation at the moving front, and S’= dS/dT. Equation (2.3) means that the
drug solubility controls the kinetics of the interface. By defining the new variables
A TDdA X S(T)(2.6) U-A, t-(AoX), x Xo’ t( t) Xo
(2.1)-(2.5) can be rewritten in a simpler way:
(2.7) ut rl
-
u,, L(t) < x < 1,
(2.8) u=0 atx=l,
(2.9) u=l
at x L(t),
(2.10) -u-(n-1)U
(2.11) L(0) 1, L(t) > 0,
where U= dL/dt and B is defined by
(2.12) r =<< 1.Ao
It is mathematically convenient to introduce a new spatial variable defined by
1-x(2.13) y 1-L(t)
and to reformulate (2.7)-(2.11) in terms of y and t"
(2.14) uyy /[(1 L)2ut + L’(1 L)yuy], 0 < y < 1,
(2.15) u=O aty=O,
(2.16) u=l
at y=l,
(2.17) u (1- L)(q -1)L’
(2.18) L(0) 1, L(t) > 0.
We then seek a solution of these equations of the form
(2.19) u(y, t, 7) uo(y, t)+ qu,(y, t)+.
(2.20) L(t, q)= Lo(t)+ TLl(t)+" .
From the leading order problem, we find Uo y and Lo 1 -(2t) 1/2. Thus, we conclude
that
(2.21) A(X, T)= A S(T)-Xo] + O(rlA)
and
(2.22) S( T) Xo-(2TDdA/Ao)’/+ O(rIXo).
Moreover, if the release rate is defined by
(2.23) M S[-DaAx]x=xo,
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where S, is the area of solute diffusion, we obtain using (2.21) and (2.22)
(2.24) M S,[DdAsAo/(2T)] 1/2,
which is exactly the Higuchi result using a pseudo-steady-state approximation [6].
Note from (2.22) that the position of the front varies like (2T) 1/2 for all time and is
typical of matrix-controlled releases. Observations of constant release for small time
have motivated modifications of the Higuchi model (partition controlled release [7]).
We now explore the advantage of swelling-controlled release by supplementing the
Higuchi model with a model for the solvent diffusion through the swellable polymer.
3. Swelling-controlled release [1], [2]. In these systems a drug is dissolved or
dispersed within a polymer matrix and is not able to diffuse through the matrix. In
contact with environmental fluid, the matrix starts to swell and the drug contained in
that part ofthe polymer diffuses through the polymer. Thus the release rate is determined
by the rate of diffusion of the solvent in the polymer. A schematic diagram of the
concentration profile in a slab matrix for the drug (full line) and the solvent (broken
line) is shown in Fig. 2. At time 0, the matrix is exposed to a penetrant that causes
swelling of the glassy polymer. The concentrations of the solute and the penetrant are
denoted by A and C, respectively. Co is the solubility of the solvent in the swollen
polymer. Two moving fronts are observed. The front located at X SI(T) separates
the solvent-free polymer from the swollen polymer; the front located at X S2(T)
A
Time 0
X
S2 (T) St (T)
A0
O S (T) S2 (T)
C0
X
Time T
FIG. 2. Swelling-controlled release. The concentration of the drug A (full line) and the concentration of
the solvent C (broken line) are represented as functions ofX.
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results from the volume expansion of the polymer due to the gradual swelling. As in
[5], we assume that S2(T) can be obtained by the following equation
s2(r)
,)(3.1) $2(T)
-Xi fi C( T, X dX’
a S(T)
where X-Xi is the initial position of the front and t3 is the molar volume of the
swelling agent. Using the Higuchi model, we describe the diffusion of the drug by
(3.2) AT DdAxx, SI(T) < X < $2(T),
(3.3) A 0 at X S2(T),
(3.4)
-DdAx (A- Ao)S at X SI(T),
(3.5) S(O)=S(O)=Xi.
These equations are equivalent to (2.1), (2.2), and (2.4). Equation (2.3) is not required
because we now assume that it is the diffusion of the swelling agent that controls the
rate of the release. We model its transport by the equations previously investigated
[10]. They are given by
(3.6) CT DCxx, S,(T) < X < S( T),
(3.7) C Co at X S(T),
(3.8)
-DCx C + K)S at X S(T),
(3.9) S = -k,(C C*) at X SI(T).
kl, K, D, Co and C* given are constant parameters. Equation (3.6) is Fick’s Diffusion
Law for a one-dimensional system subject to a fixed concentration at X S2(T) (3.7).
Equation (3.9) describes the swelling kinetics as an interface reaction: the excess
C(X, T)- C* over the equilibrium value C* drives the penetrant front at some finite
rate. In this equation kl and n represent phenomenological quantities. Equation (3.8)
is a mass balance at the moving front. It is derived in the following way: the flux from
the swelling region across X SI(T) is given by DCx + CS and is assumed to be
proportional to the flux generated by the interface region. Thus we have
DCx + CS k_( C C*) at X $1(T),
and using (3.9), we obtain (3.8) with K- kffkl.
Our model for the diffusion of the drug and the solvent is similar to the problem
formulated by Peppas et al. [5]. It mainly differs from our formulation by the equations
at the moving front. In its one-phase formulation (e D1/D =0 in [5]), the model
proposed by Peppas et al. assumed Cx- O, C- C*, and Ax- 0 at X- SI(T). These
conditions can be obtained from (3.4), (3.8), and (3.9) provided that Dd, D, and kl
are sufficiently large. In order to analyze (3.1)-(3.9), we first introduce the dimensionless
variables u, v, t, x, L1, and L2 defined by
C-C* A T(3.10a) U=Co_C., v= t-a,
X
L, X S(T)(3.10b) x=fl, fl, L(t)= fl (j= 1 or 2)
where
D(Co- C*) 1-2n(3.10c) a k fl
D(Co- C* ’-"
Ckl
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and
(3.10d)
Then (3.1)-(3.9) become:
(3.11)
(3.12)
(3.13)
(3.14)
(3.15)
(3.16)
(3.17)
(3.18)
(3.19)
=C*+K.
where e is a control parameter defined by
(3.20) e >0.C
The results of our previous study [10] indicate that zero-order release can be achieved
for a long period of time if e is sufficiently small. This suggests analyzing (3.11)-(3.19)
in the limit e
-
0. To this end, we seek a solution of these equations of the form
(3.21)
(3.22)
where
u(t, y, e)= Uo(t, y)+ eul(t, y)+"
v(t, y, e)+vo(t, y)+ev,(t, y)+"
(3.23) y
and
(3.24) Lj(t, e):Ljo(t)+eL(t)+’.. (j= or 2).
After introducing (3.21)-(3.24) into (3.12)-(3.20) and equating to zero the coefficients
of each power of e, we obtain the following problems for Uo and Vo"
(3.25)
(3.26)
(3.27)
(3.28)
(3.29)
(3.30)
UOyy l)Oyy 0, 0 < y < 1,
uo-l=vo=0 aty=l,
Uoy (L20- Lo)Lo, roy 0 at y 0,
Lo=-Uo aty=0,
L20(t)- Li C*[L20(t)- Llo(t)],
Llo(0) L20(0)=
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These equations are easily solved. We find that
(3.31) uo(y, t)= F(t)(y- 1)+ 1,
where F(t) satisfies the conditions
(3.32)
(3.33)
and
-F=(Luo-Llo)Lo,
Lo -(1 F)"
Vo(y, t) 0
(3.34) Lzo(t) Li C*Lo((1- C*)
Using (3.34), we can eliminate L2o(t) in (3.32) and (3.33):
(3.35) -F( 1 3C*) (Li Lo)Lo,
(3.36) Lo -( 1 F) n.
By defining Lo Li- Lo, the problem (3.35)-(3.36) becomes similar to (2.49)-(2.50)
in [10]
(3.37) F(1 C*) LoLl,
(3.38) L= (1- F)
Eliminating L, we obtain Lo Lo(F(t))
F(1 7C*)(3.39) Lo(F(t)) (l-F)"
where F>= 0. Then using (3.39) and (3.38), we obtain a differential equation for F(t)
which can be integrated. As a simple illustration, we consider the case n 1. Using
(3.39), (3.38) is easily solved. We find that
(3.40) Lo Li- Lo(t)= -F+ (F+ 2Ft) 1/2
where F (1 3C*). Of particular interest is the small time behavior. From (3.40), we
find that
(3.41) Li- Llo(t) +-+ O(t3).
Since Vo O, we must analyze the problem for v(y, t) which is given by
(3.42) )lyy O, 0 < y < 1,
(3.43) vl=0 aty=l,
(3.44)
D Vly=(L2o Lo)Lo at y 1.
From (3.42) and (3.43), we find that
(3.45) vl(y, t) G( t)(y 1)
where G(t) is an arbitrary function of which is determined using (3.44):
D(3.46) G(t) =-A--(Leo- Llo)Lo.
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In conclusion, using the definition of y, (3.44) and (3.45), we find that the concentration
of the drug is given by
D(3.47) v(x, t) eL’lo(x L2o) + O(e2)
Dd
or equivalently
(3.48) A(X, T)--, Aoe D
--
L ofl X S T
With (3.48), we can determine the drug release rate M Su[-DdAx]x=s2. It is given
by
(3.49) M- S.Ao[ S’I(O)]L’lo
where S(0) is the initial velocity of the polymer front. It is defined by (3.9) with the
initial condition C(Xi, O)= Co. Since Lo"-1 for small time (from (3.35) and (3.36),
F---0 and L’lo’-"-1 near 0), the drug release rate is constant initially. The expression
(3.49) is in agreement with the ideas formulated by Peppas and Franson [9].
4. Discussion. In this paper, we have formulated and analyzed a mathematical
model for the swelling controlled release of drugs. The model combines Higuchi
equations [3a], [3b] and Astarita and Sarti equations [4] for the diffusion of the drug
and the solvent, respectively.
In 2, we show that Higuchi’s approximation (the so-called pseudo-steady-state
approximation) represents the first term of an asymptotic expansion. The small
parameter used in this expansion is r/- AsAo where As and A0 are the solute solubility
and the solute initial loading, respectively. Although Higuchi equations can be solved
exactly [11] and better approximative solutions have been proposed [12], our
asymptotic approach is a systematic method to obtain higher order corrections. Because
of its simplicity, it can also be used to analyze more complex moving boundary
problems.
In the second part of the paper, we proposed a similar asymptotic method to
analyze our model for the diffusion of the drug and the solvent. The small parameter
is now given by e which is proportional to the deviation Co-C* where Co is the
concentration of the solvent at the polymer/solvent interface and C* corresponds to
the equilibrium value of the solvent concentration in the polymer. As in our previous
analysis, the first term of our asymptotic expansion represents a quasi-steady-state
approximation for both the drug and the solvent. The drug release rate is given by
(3.49) and is constant for small time: M SuAoS’(O) SuAokl(Co- C*)". This constant
is proportional to the deviation Co-C*. We note that the volume expansion of the
polymer does not contribute to the expression of M for small time.
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